Literature DB >> 11086021

Tangier disease as a test of the reverse cholesterol transport hypothesis.

A R Tall1, N Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11086021      PMCID： PMC381442          DOI： 10.1172/JCI11538

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  31 in total

1.  Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

Authors:  P Costet; Y Luo; N Wang; A R Tall
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.

Authors:  M N Nanjee; C J Cooke; W L Olszewski; N E Miller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

3.  The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines.

Authors:  A E Bortnick; G H Rothblat; G Stoudt; K L Hoppe; L J Royer; J McNeish; O L Francone
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

4.  Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells.

Authors:  C G Panousis; S H Zuckerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

5.  Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

Authors:  N Wang; D L Silver; P Costet; A R Tall
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

6.  Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.

Authors:  M E Brousseau; G P Eberhart; J Dupuis; B F Asztalos; A L Goldkamp; E J Schaefer; M W Freeman
Journal:  J Lipid Res       Date:  2000-07       Impact factor: 5.922

Review 7.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

9.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.

Authors:  J McNeish; R J Aiello; D Guyot; T Turi; C Gabel; C Aldinger; K L Hoppe; M L Roach; L J Royer; J de Wet; C Broccardo; G Chimini; O L Francone
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice.

Authors:  T Arai; F Rinninger; L Varban; V Fairchild-Huntress; C P Liang; W Chen; T Seo; R Deckelbaum; D Huszar; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205
View more
  25 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  Is it time to modify the reverse cholesterol transport model?

Authors:  A R Tall; N Wang; P Mucksavage
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport.

Authors:  W R Oliver; J L Shenk; M R Snaith; C S Russell; K D Plunket; N L Bodkin; M C Lewis; D A Winegar; M L Sznaidman; M H Lambert; H E Xu; D D Sternbach; S A Kliewer; B C Hansen; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

4.  Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies.

Authors:  Sadik H Kassim; James M Wilson; Daniel J Rader
Journal:  Clin Lipidol       Date:  2010-06

5.  Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

Authors:  Satoshi Takahashi; Keiju Hiromura; Mayuko Tsukida; Yuko Ohishi; Hiroko Hamatani; Noriyuki Sakurai; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Akito Maeshima; Takashi Kuroiwa; Hideaki Yokoo; Takeo Aoki; Michio Nagata; Yoshihisa Nojima
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

6.  Interleukin-10 facilitates both cholesterol uptake and efflux in macrophages.

Authors:  Xinbing Han; Shiro Kitamoto; Qingyu Lian; William A Boisvert
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

7.  Endothelial Dysfunction: An Early Cardiovascular Risk Marker in Asymptomatic Obese Individuals with Prediabetes.

Authors:  Alok K Gupta; Eric Ravussin; Darcy L Johannsen; April J Stull; William T Cefalu; William D Johnson
Journal:  Br J Med Med Res       Date:  2012-05-30

8.  The role of hydrophobic and negatively charged surface patches of lipid-free apolipoprotein A-I in lipid binding and ABCA1-mediated cholesterol efflux.

Authors:  Loren E Smith; W Sean Davidson
Journal:  Biochim Biophys Acta       Date:  2009-09-24

9.  An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages.

Authors:  Loren E Faulkner; Stacey E Panagotopulos; Jacob D Johnson; Laura A Woollett; David Y Hui; Scott R Witting; J Nicholas Maiorano; W Sean Davidson
Journal:  J Lipid Res       Date:  2008-03-22       Impact factor: 5.922

10.  Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.

Authors:  Brandee L Wagner; Annabel F Valledor; Gang Shao; Chris L Daige; Eric D Bischoff; Mary Petrowski; Kristen Jepsen; Sung Hee Baek; Richard A Heyman; Michael G Rosenfeld; Ira G Schulman; Christopher K Glass
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.